Zobrazeno 1 - 10
of 125
pro vyhledávání: '"Yuanbo Feng"'
Autor:
Lei Chen PhD, Mingyuan Yuan MD, Xinqi Zhang MD, Yongsheng Li MD, Yuanbo Feng PhD, Jie Yu MD, Walter Coudyzer PhD, Yiyang Xie MS, Jiayue Xu MS, Yuzhen Li MS, Yue Li PhD, Yicheng Ni MD, PhD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 22 (2023)
Conforming to the current replace–reduce–refine 3Rs’ guidelines in animal experiments, a series of explorative efforts have been made to set up operable biomedical imaging-guided platforms for qualitative and quantitative evaluations on pharmac
Externí odkaz:
https://doaj.org/article/56230509022e45158ad6d7850b9c9e17
Autor:
Lei Chen, Zhongqiang Wang, Xubin Fu, Shuncong Wang, Yuanbo Feng, Walter Coudyzer, Shugeng Wu, Haijun Zhang, Zhihong Chai, Yue Li, Yicheng Ni
Publikováno v:
Poultry Science, Vol 102, Iss 9, Pp 102902- (2023)
ABSTRACT: Driven by a global trend of applying replace-reduce-refine or 3Rs’ guidance for experimental animals in life sciences, chick embryo and particularly allantois with its chorioallantoic membrane have been increasingly utilized to substitute
Externí odkaz:
https://doaj.org/article/aa21d1c175e247ee9ba87ec536c10e30
Autor:
Shuncong Wang, Xin Pang, Frederik de Keyzer, Yuanbo Feng, Johan V. Swinnen, Jie Yu, Yicheng Ni
Publikováno v:
Acta Neuropathologica Communications, Vol 11, Iss 1, Pp 1-12 (2023)
Abstract Automatic segmentation of rodent brain tumor on magnetic resonance imaging (MRI) may facilitate biomedical research. The current study aims to prove the feasibility for automatic segmentation by artificial intelligence (AI), and practicabili
Externí odkaz:
https://doaj.org/article/7f8d77b286a542a38e10cea2116f4f83
Autor:
Yue Li PhD, Shuncong Wang MD, Lei Chen MD, Yuanbo Feng PhD, Zhijun Shen BD, Xin Chen PhD, Gang Huang PhD, Yicheng Ni PhD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 21 (2022)
Radical treatment of malignant solid tumors should aim to be less traumatic, precise, and effective. OncoCiDia, as a noninvasive, sequential dual-targeting, small-molecule, broad spectrum anticancer theranostic approach, may fulfill these requirement
Externí odkaz:
https://doaj.org/article/974f798911a646a998cc02065d50f97f
Autor:
Yewei Liu, Qiu Guan, Xiangyong Kong, Frederik De Keyzer, Yuanbo Feng, Feng Chen, Jie Yu, Jianjun Liu, Shaoli Song, Jos van Pelt, Johan Swinnen, Guy Bormans, Raymond Oyen, Shuncong Wang, Gang Huang, Yicheng Ni, Yue Li
Publikováno v:
Translational Oncology, Vol 13, Iss 1, Pp 92-101 (2020)
To evaluate hepatobiliary-specific contrast agent (CA) mangafodipir trisodium (Mn-DPDP)–enhanced magnetic resonance imaging (MRI) for predicting the therapeutic efficacy of the vascular disrupting agent combretastatin A4 phosphate (CA4P) in rats wi
Externí odkaz:
https://doaj.org/article/634fff80f6df4f6ebf33f2602b80e634
Autor:
Lei Chen, Shuncong Wang, Yuanbo Feng, Jinyong Zhang, Yuqing Du, Jiang Zhang, Chantal Van Ongeval, Yicheng Ni, Yue Li
Publikováno v:
Cells, Vol 10, Iss 2, p 463 (2021)
The fertilised chick egg and particularly its chorioallantoic membrane (CAM) have drawn continuing interest in biomedicine and bioengineering fields, especially for research on vascular study, cancer, drug screening and development, cell factors, ste
Externí odkaz:
https://doaj.org/article/a875fad883f74e6c9c23b58b2b6eef35
Autor:
Yewei Liu, Shuncong Wang, Xiaohui Zhao, Yuanbo Feng, Guy Bormans, Johan Swinnen, Raymond Oyen, Gang Huang, Yicheng Ni, Yue Li
Publikováno v:
Diagnostics, Vol 10, Iss 2, p 78 (2020)
Vascular disrupting agents (VDAs) have entered clinical trials for over 15 years. As the leading VDA, combretastatin A4 phosphate (CA4P) has been evaluated in combination with chemotherapy and molecular targeting agents among patients with ovarian ca
Externí odkaz:
https://doaj.org/article/451b81dead854dbe949867de863e95b1
Autor:
Junjie Li, Feng Chen, Yuanbo Feng, Marlein Miranda Cona, Jie Yu, Alfons Verbruggen, Jian Zhang, Raymond Oyen, Yicheng Ni
Publikováno v:
Translational Oncology, Vol 6, Iss 1, Pp 42-50 (2013)
OBJECTIVE: Differently located tumors of the same origin may exhibit diverse responses to the same therapeutics. To test this hypothesis, we compared the responses of rodent hepatic and subcutaneous engrafts of rhabdomyosarcoma-1 (R1) to a vascular d
Externí odkaz:
https://doaj.org/article/8d27742ce1a346029154537af41e8c31
Autor:
Feng Chen, Yingmei Feng, Kaier Zheng, Frederik De Keyzer, Junjie Li, Yuanbo Feng, Marlein Miranda Cona, Huaijun Wang, Yansheng Jiang, Jie Yu, Guy Marchal, Catherine Verfaillie, Bart De Geest, Raymond Oyen, Yicheng Ni
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e41140 (2012)
A key problem in solid tumor therapy is tumor regrowth from a residual viable rim after treatment with a vascular disrupting agent (VDA). As a potential solution, we studied a combined treatment of a VDA and antiangiogenic. This study was approved by
Externí odkaz:
https://doaj.org/article/772584ae568d4c998d641985b24ecda2
Autor:
Haili, Wang, Guofang, Cheng, Lili, Quan, Haibo, Qu, Ailing, Yang, Jiangge, Ye, Yuanbo, Feng, Xiaofang, Li, Xiaoli, Shi, Hua, Pan
Publikováno v:
Metabolic Brain Disease. 37:1373-1386
Sevoflurane is a common used inhaled anesthetic that was reported to regulate the progression of multiple cancers. Here, we aimed to investigate the function and regulatory mechanism underlying sevoflurane in glioma cells.A172 and U251 cells were tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bb3e70b0b29d9e7ca9cf48f2f7de759
https://doi.org/10.1007/s11011-022-00959-w
https://doi.org/10.1007/s11011-022-00959-w